GoAI
Get started
Jinxin Fertility Group Limited logo

Jinxin Fertility Group Limited

1951.HK

HKSEHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

HK$2.235

+HK$0.005 · +0.22%

Aug 24, 4:08 PM HKT

1951.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Jinxin Fertility Group Limited is an investment holding company that specializes in providing assisted reproductive services (ARS) across both China and the United States. Its core offerings primarily include two types of treatment: artificial insemination, which can be performed using either the husband's or a donor's sperm, and advanced in vitro fertilization (IVF) technologies, ranging from conventional IVF with embryo transfer to IVF utilizing intracytoplasmic sperm injection (ICSI). To complement its ARS treatments, the company also furnishes a range of supportive services such as nutritional guidance, traditional Chinese medicine therapies, and psychological counseling. Beyond fertility-specific care, Jinxin Fertility Group extends its operations to include management services, general medical care encompassing gynecology, urology, and internal medicine, as well as ambulatory surgery center facilities and other ancillary medical services. Furthermore, the company conducts pre-implantation genetic screening tests. Its business scope also diversifies into investment management, management consulting, and real estate development and operation. Jinxin Fertility Group Limited was established in 2003 and has its corporate headquarters located in Chengdu, China.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
CN
CEO
Yang Dong
Listed since
Jun 25, 2019
Employees
3,494

Market position

Day range

Current HK$2.235

52-week range

Current HK$2.235

Open
HK$2.23
Previous close
HK$2.23
Volume
21.26M
1.64× average
Average volume
12.95M
Average daily volume
Market cap
5.94B HKD
Beta
0.79
Market reference 1
50-day average
HK$2.1329
+4.79% above average
200-day average
HK$2.3462
-4.74% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
7.92B CNY
P/E (TTM)
26.62×
P/B (TTM)
0.57×
P/S (TTM)
1.89×
EV / EBITDA
14.7×
Earnings yield
-16.22%
Free cash flow yield
3.72%
Dividend yield
1.87%

Profitability & efficiency

Gross margin
35.19%
Operating margin
11.34%
Net margin
6.26%
Return on equity
-10.40%
Return on assets
-6.81%
Return on invested capital
1.50%

Financial health

Debt / equity
0.34×
Current ratio
0.87×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends50%18%-13%-45%Gross margin, FY2021: 41.96%Gross margin, FY2022: 38.62%Gross margin, FY2023: 42.15%Gross margin, FY2024: 39.10%Gross margin, FY2025: 31.72%Operating margin, FY2021: 20.20%Operating margin, FY2022: 12.07%Operating margin, FY2023: 17.23%Operating margin, FY2024: 15.71%Operating margin, FY2025: 7.67%Net margin, FY2021: 18.48%Net margin, FY2022: 5.12%Net margin, FY2023: 12.36%Net margin, FY2024: 10.07%Net margin, FY2025: -36.85%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 41.96%. Gross margin FY2022 38.62%. Gross margin FY2023 42.15%. Gross margin FY2024 39.10%. Gross margin FY2025 31.72%. Operating margin FY2021 20.20%. Operating margin FY2022 12.07%. Operating margin FY2023 17.23%. Operating margin FY2024 15.71%. Operating margin FY2025 7.67%. Net margin FY2021 18.48%. Net margin FY2022 5.12%. Net margin FY2023 12.36%. Net margin FY2024 10.07%. Net margin FY2025 -36.85%.

Income trends

Revenue

2.58B CNY-8.22%

Operating income

197.93M CNY-55.18%

Net income

−950.88M CNY−1.23B CNY
Income trends across reported periods3.19B CNY1.68B CNY177.86M CNY−1.33B CNYRevenue, FY2021: 1.84B CNYRevenue, FY2022: 2.36B CNYRevenue, FY2023: 2.79B CNYRevenue, FY2024: 2.81B CNYRevenue, FY2025: 2.58B CNYOperating income, FY2021: 371.39M CNYOperating income, FY2022: 285.37M CNYOperating income, FY2023: 480.47M CNYOperating income, FY2024: 441.58M CNYOperating income, FY2025: 197.93M CNYNet income, FY2021: 339.9M CNYNet income, FY2022: 121.12M CNYNet income, FY2023: 344.72M CNYNet income, FY2024: 283.1M CNYNet income, FY2025: −950.88M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.84B CNY. Revenue FY2022 2.36B CNY. Revenue FY2023 2.79B CNY. Revenue FY2024 2.81B CNY. Revenue FY2025 2.58B CNY. Operating income FY2021 371.39M CNY. Operating income FY2022 285.37M CNY. Operating income FY2023 480.47M CNY. Operating income FY2024 441.58M CNY. Operating income FY2025 197.93M CNY. Net income FY2021 339.9M CNY. Net income FY2022 121.12M CNY. Net income FY2023 344.72M CNY. Net income FY2024 283.1M CNY. Net income FY2025 −950.88M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue2.58B CNY2.81B CNY2.79B CNY2.36B CNY1.84B CNY
Cost of goods sold1.76B CNY1.71B CNY1.61B CNY1.45B CNY1.07B CNY
Gross profit818.44M CNY1.1B CNY1.18B CNY913.13M CNY771.48M CNY
Research and development20.11M CNY24.69M CNY21.75M CNY17.47M CNY10.65M CNY
Selling, general, and administrative662.71M CNY633.18M CNY673.23M CNY610.29M CNY389.45M CNY
Operating expenses620.51M CNY657.87M CNY694.97M CNY627.76M CNY400.1M CNY
Interest income9.15M CNY7.48M CNY20.71M CNY28.35M CNY34.45M CNY
Interest expense69.22M CNY57.41M CNY79.64M CNY71.85M CNY21.15M CNY
Depreciation and amortization340.67M CNY203.48M CNY201.55M CNY190.85M CNY122.7M CNY
Operating income197.93M CNY441.58M CNY480.47M CNY285.37M CNY371.39M CNY
Net income−950.88M CNY283.1M CNY344.72M CNY121.12M CNY339.9M CNY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
43%
3 beats, 3 misses, 1 met estimate
Average EPS surprise
-125.76%
7 comparable reports
Latest EPS result
0.05
Estimate 0.03 · Beat by 33.33%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.13-0.07-0.27-0.47Q3 '23BeatQ1 '24BeatQ3 '24MissQ1 '25MissQ3 '25MissQ1 '26MetQ3 '26BeatQ1 '27Estimate
Q3 2023, reported Aug 30, 2023: actual 0.088, estimate 0.076, surprise +16.92%, Beat. Q1 2024, reported Mar 27, 2024: actual 0.066, estimate 0.066, surprise +0.14%, Beat. Q3 2024, reported Aug 30, 2024: actual 0.075, estimate 0.086, surprise -12.22%, Miss. Q1 2025, reported Mar 28, 2025: actual 0.036, estimate 0.064, surprise -43.17%, Miss. Q3 2025, reported Aug 25, 2025: actual -0.425, estimate 0.055, surprise -875.29%, Miss. Q1 2026, reported Mar 26, 2026: actual 0.033, estimate 0.033, surprise 0.00%, Met estimate. Q3 2026, reported Aug 21, 2026: actual 0.046, estimate 0.035, surprise +33.33%, Beat. Q1 2027, reported Mar 31, 2027: actual —, estimate 0.047, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates3.58B2.8B2.03B1.25BQ3 '23MissQ1 '24MissQ3 '24MissQ1 '25MissQ3 '25MissQ1 '26BeatQ3 '26BeatQ1 '27Estimate
Q3 2023, reported Aug 30, 2023: actual 1.44B HKD, estimate 1.48B HKD, surprise -2.24%, Miss. Q1 2024, reported Mar 27, 2024: actual 1.65B HKD, estimate 3.42B HKD, surprise -51.87%, Miss. Q3 2024, reported Aug 30, 2024: actual 1.55B HKD, estimate 1.59B HKD, surprise -2.26%, Miss. Q1 2025, reported Mar 28, 2025: actual 1.46B HKD, estimate 1.64B HKD, surprise -11.22%, Miss. Q3 2025, reported Aug 25, 2025: actual 1.41B HKD, estimate 1.48B HKD, surprise -4.74%, Miss. Q1 2026, reported Mar 26, 2026: actual 1.51B HKD, estimate 1.48B HKD, surprise +2.28%, Beat. Q3 2026, reported Aug 21, 2026: actual 1.58B HKD, estimate 1.58B HKD, surprise +0.20%, Beat. Q1 2027, reported Mar 31, 2027: actual —, estimate 1.73B HKD, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.0595

2024 complete year-12.5% since 2020

2026 partial: HK$0.0418

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Jun 29, 2026

HK$0.0418

Irregular

Record Jun 30, 2026 · Payment Jul 28, 2026

Dividend

Ex-dividend Jun 27, 2024

HK$0.0595

Irregular

Record Jun 28, 2024 · Payment Jul 25, 2024

Dividend

Ex-dividend Jun 30, 2022

HK$0.0738

Irregular

Record Jul 5, 2022 · Payment Jul 22, 2022

Dividend

Ex-dividend Jul 2, 2020

HK$0.068

Irregular

Record Jul 6, 2020 · Payment Jul 29, 2020

1951.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.7

-3.94%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.46

-3.61%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$221.4

-2.89%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.60

-4.71%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$99.50

-2.83%

ETFs holding 1951.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
9.12M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.095-0.70%
Vanguard FTSE Emerging Markets ETF logoVanguard FTSE Emerging Markets ETFVWO
Market value
8.51M
Weight
0.01%
AUM
162.3B USD
Expense ratio
0.06%
Price / 1D
$59.905-0.90%
iShares Core MSCI Emerging Markets ETF logoiShares Core MSCI Emerging Markets ETFIEMG
Market value
7.29M
Weight
0.00%
AUM
160B USD
Expense ratio
0.09%
Price / 1D
$80.38-1.46%
Avantis Emerging Markets Equity ETF logoAvantis Emerging Markets Equity ETFAVEM
Market value
5.13M
Weight
0.02%
AUM
27.89B USD
Expense ratio
0.33%
Price / 1D
$92.93-1.38%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
2.63M
Weight
0.02%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$158.97-0.68%
Dimensional - Emerging Markets Core Equity 2 ETF logoDimensional - Emerging Markets Core Equity 2 ETFDFEM
Market value
1.21M
Weight
0.01%
AUM
9.49B USD
Expense ratio
0.39%
Price / 1D
$39.445-1.21%
iShares Core MSCI Total International Stock ETF logoiShares Core MSCI Total International Stock ETFIXUS
Market value
1.03M
Weight
0.00%
AUM
60.91B USD
Expense ratio
0.07%
Price / 1D
$97.285-0.67%
Dimensional World ex U.S. Core Equity 2 ETF logoDimensional World ex U.S. Core Equity 2 ETFDFAX
Market value
623.18K
Weight
0.00%
AUM
12.57B USD
Expense ratio
0.28%
Price / 1D
$37.90-0.68%

Continue in GoAI

Research 1951.HK

research.disclaimer